PET imaging test for people with liver injury
Part of Digestive system clinical trials.
This study tests a new PET imaging agent called ¹⁸F-DFA to see if it can measure liver damage and liver failure. It may help doctors better understand your liver condition using a specialized scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 80 years old
- Diagnosed with liver damage (for example, based on abnormal liver enzyme levels in your blood)
- Diagnosed with liver failure (severe liver damage causing symptoms like extreme tiredness, yellowing skin or eyes, bleeding problems, or confusion)
- Able to give informed consent and follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan (68Ga-FAPI) to see how well systemic therapy is working in people with advanced liver cancer that can't be removed by surgery. The goal is to find a better way to measure treatment effectiveness.
This study uses a special PET scan to look for inflammation in the brain related to fatty liver disease. It may help researchers understand how liver health affects brain function.
This trial studies how well a special imaging test (68Ga-FAPI PET/MRI) can detect and evaluate hepatocellular carcinoma (HCC), a type of liver cancer. It may help doctors confirm diagnosis and plan next steps by seeing how the cancer takes up the tracer.
This study tests whether a new type of MRI scan can better detect and measure liver disease, including fatty liver and scarring, compared to standard CT scans. If you have chronic liver disease, this study may help improve how we diagnose and track it.
This study uses a special PET scan drug (Ga-FAPI-46) to create clearer pictures of pancreatic and bile duct cancers. It may help doctors decide on the best next steps—especially before surgery—by checking tumor size and looking for spread.
This study compares two advanced imaging techniques — a combined PET/MR scan and an enhanced MRI — to see which one better finds and shows liver tumors or cancer that has spread to the liver. If you have signs of a liver problem, this trial may help doctors get a clearer picture of your condition.
Hear when a new Liver Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.